Cargando…
Intradermal grass pollen immunotherapy increases T(H)2 and IgE responses and worsens respiratory allergic symptoms
BACKGROUND: Repeated low-dose grass pollen intradermal allergen injection suppresses allergen-induced cutaneous late-phase responses comparably with conventional subcutaneous and sublingual immunotherapy. OBJECTIVE: We sought to evaluate the efficacy and safety of grass pollen intradermal immunother...
Autores principales: | Slovick, Anna, Douiri, Abdel, Muir, Rachel, Guerra, Andrea, Tsioulos, Konstantinos, Hay, Evie, Lam, Emily P.S., Kelly, Joanna, Peacock, Janet L., Ying, Sun, Shamji, Mohamed H., Cousins, David J., Durham, Stephen R., Till, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mosby
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457129/ https://www.ncbi.nlm.nih.gov/pubmed/27773851 http://dx.doi.org/10.1016/j.jaci.2016.09.024 |
Ejemplares similares
-
Influence of seasonal exposure to grass pollen on local and peripheral blood IgE repertoires in patients with allergic rhinitis
por: Wu, Yu-Chang B., et al.
Publicado: (2014) -
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
por: Focke-Tejkl, Margarete, et al.
Publicado: (2015) -
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
por: Chen, Jiun-Bo, et al.
Publicado: (2017) -
Protocol for a double-blind randomised controlled trial of low dose intradermal grass pollen immunotherapy versus a histamine control on symptoms and medication use in adults with seasonal allergic rhinitis (PollenLITE)
por: Slovick, Anna, et al.
Publicado: (2013) -
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD
por: Zhu, Jie, et al.
Publicado: (2020)